Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Corvatta

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Expert Review of Hematology|May 31, 2022
An update on novel multiple myeloma targetsMassimo Offidani, Laura Corvatta, Sonia Morè, et al.
Expert Review of Hematology|March 13, 2020
Developments in consolidation and maintenance strategies in post-remission multiple myelomaSonia Morè, Laura Corvatta, Laura Maracci, et al.
Oncotargets and Therapy|October 11, 2014
An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosed multiple myelomaMassimo Offidani, Laura Corvatta, Patrizia Caraffa, et al.
Expert Opinion on Investigational Drugs|April 8, 2011
How to treat patients with relapsed/refractory multiple myeloma: evidence-based information and opinionsMassimo Offidani, Laura Corvatta, Fortunato Morabito, et al.
Expert Review of Anticancer Therapy|April 18, 2014
Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical dataMassimo Offidani, Laura Corvatta, Patrizia Caraffa, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma TreatmentSonia Morè, Laura Corvatta, Valentina Maria Manieri, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 16, 2006
Diagnostic value of C-reactive protein in discriminating fungal from nonfungal pulmonary infiltrates in patients with hematologic malignanciesMassimo Offidani, Laura Corvatta, Lara Malerba, et al.
Pharmaceuticals (Basel, Switzerland)|December 2, 2020
Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma TreatmentSonia Morè, Maria Teresa Petrucci, Laura Corvatta, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 14, 2025
Novelties on Multiple Myeloma from the Main 2024 Hematology ConferencesSonia Morè, Laura Corvatta, Valentina Maria Manieri, et al.
Current Cancer Drug Targets|September 24, 2016
Stem Cell Transplantation in Multiple MyelomaMassimo Offidani, Silvia Gentili, Francesca Gay, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Expert Review of Hematology|May 31, 2022
An update on novel multiple myeloma targetsMassimo Offidani, Laura Corvatta, Sonia Morè, et al.
Expert Review of Hematology|March 13, 2020
Developments in consolidation and maintenance strategies in post-remission multiple myelomaSonia Morè, Laura Corvatta, Laura Maracci, et al.
Oncotargets and Therapy|October 11, 2014
An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosed multiple myelomaMassimo Offidani, Laura Corvatta, Patrizia Caraffa, et al.
Expert Opinion on Investigational Drugs|April 8, 2011
How to treat patients with relapsed/refractory multiple myeloma: evidence-based information and opinionsMassimo Offidani, Laura Corvatta, Fortunato Morabito, et al.
Expert Review of Anticancer Therapy|April 18, 2014
Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical dataMassimo Offidani, Laura Corvatta, Patrizia Caraffa, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma TreatmentSonia Morè, Laura Corvatta, Valentina Maria Manieri, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 16, 2006
Diagnostic value of C-reactive protein in discriminating fungal from nonfungal pulmonary infiltrates in patients with hematologic malignanciesMassimo Offidani, Laura Corvatta, Lara Malerba, et al.
Pharmaceuticals (Basel, Switzerland)|December 2, 2020
Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma TreatmentSonia Morè, Maria Teresa Petrucci, Laura Corvatta, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 14, 2025
Novelties on Multiple Myeloma from the Main 2024 Hematology ConferencesSonia Morè, Laura Corvatta, Valentina Maria Manieri, et al.
Current Cancer Drug Targets|September 24, 2016
Stem Cell Transplantation in Multiple MyelomaMassimo Offidani, Silvia Gentili, Francesca Gay, et al.
Pageof 5